-
The role of perioperative chemoimmunotherapy in resectable non-small cell lung cancer: insights from the NADIM trial
de Koning, A., Houda, I., Ulas, E. B. & Bahce, I., 31 Jul 2025, In: Translational lung cancer research. 14, 7, p. 2383-2386Research output: Contribution to journal › Comment/Letter to the editor* › Academic
-
An international and multidisciplinary EORTC survey on resectability of stage III non-small cell lung cancer
Houda, I., Bahce, I., Dickhoff, C., Kroese, T. E., Kroeze, S. G. C., Mariolo, A. V., Tagliamento, M., Moliner, L., Brandão, M., Pretzenbacher, Y., Edwards, J., Opitz, I., Brunelli, A., Guckenberger, M., van Schil, P. E., Popat, S., Blum, T., Faivre-Finn, C., de Ruysscher, D. & Remon, J. & 4 others, , 1 Jan 2025, In: Lung Cancer. 199, 108061.Research output: Contribution to journal › Article* › Academic › peer-review
-
Single-arm trial of neoadjuvant ipilimumab plus nivolumab with chemoradiotherapy in patients with resectable and borderline resectable lung cancer: The INCREASE study
Bahce, I., Dickhoff, C., Schneiders, F. L., Veltman, J., Heineman, D. J., Hashemi, S. M. S., Vrijmoet, A., Houda, I., Ulas, E. B., Bakker, J., van de Ven, P., Bouwhuis, N., Meijboom, L. J., Oprea-Lager, D. E., van Maldegem, F., Fransen, M. F., de Gruijl, T. D., Radonic, T. & Senan, S., 30 Sept 2024, In: Journal for Immunotherapy of Cancer. 12, 9, e009799.Research output: Contribution to journal › Article* › Academic › peer-review
- All publications
